The New Normal: How are vaccines working vs. the omicron variant?
News 12's Elizabeth Hashagen was joined by FDA advisory panel member Dr. Paul Offit to discuss COVID-19 vaccines, boosters and the variants.
Pfizer announced this morning that results from an initial laboratory study show that three doses of its COVID-19 vaccine neutralize the omicron variant, while two doses were significantly less effective.
What does this? Are you protected against serious infection? Does the omicron variant mean everyone will need boosters?
How do we reach people who are unvaccinated or are skeptical about the science?
An expert committee voted narrowly to recommend that the Food and Drug Administration authorize a COVID-19 pill from Merck for high-risk adults.
Do you think that a healthy person under the age of 50 needs to be boosted before they go to their holiday party?